CAS No. |
863239-61-6 |
中文名称 |
2-(((R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-乙基-3,7-二羟基-10,13-二甲基-十六氢-1H-环戊并[a]菲-17-基)戊酰)氨基)乙烷-1-磺酸 |
英文名称 |
2-((R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid |
别名 |
Obeticholic Acid Impurity 4/Tauro-Obeticholic Acid/2-((R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-Ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid;Ethanesulfonic acid, 2-[[(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxy-24-oxocholan-24-yl]amino]-;Obeticholic Acid Impurity 56;Tauro-Obeticholic Acid
DISCONTINUED. Please see T009025.;2H4]-Tauro-obeticholic acid;microorganisms,FXR,Tauro-Obeticholic acid,colon,NR1H4,TauroObeticholic acid,inhibit,ileum,Inhibitor,Tauro Obeticholic acid,metabolite,liver;Tauro-Obeticholic Acid;Tauro-Obeticholic acid, 10 mM in DMSO |
标准英文名 |
2-((R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid |
MDL No. |
MFCD00953614 |
分子式 |
C28H49NO6S |
分子量 |
527.77
|
精确分子量 |
527.33
|
SMILES |
CC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12 |
标准SMILES |
C[C@H](CCC(=O)NCCS(O)(=O)=O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1[C@@H](CC)[C@H]3O |
用途 |
Tauro-Obeticholic acid is an active metabolite formed by conjugation of Obeticholic acid with taurine in the liver; it is secreted into bile and acts as a farnesoid X receptor (FXR/NR1H4) agonist. It may be deconjugated by microorganisms in the ileum and colon to regenerate the parent drug, Obeticholic acid, which can then be reabsorbed or excreted in feces. |
InChIKey |
JEZXQTZLWHAKAC-NQGMLVFVSA-N |